A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis. [electronic resource]
Producer: 20170905Description: e0176660 p. digitalISSN:- 1932-6203
- Adult
- Antitubercular Agents -- therapeutic use
- Biomarkers -- blood
- C-Reactive Protein -- analysis
- Chemokine CXCL10 -- blood
- Female
- Humans
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Predictive Value of Tests
- Serum Amyloid A Protein -- analysis
- Tuberculosis, Multidrug-Resistant -- blood
- Vascular Endothelial Growth Factor A -- blood
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.